🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07046390
Starting soon Not applicable

TIPS Block vs. IV Analgesia for Postoperative Pain After Knee Arthroscopy

NCT07046390 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-07-20
Last updated
2025-07-01

Condition(s) studied

Knee Arthroscopic SurgeryNerve Block

Investigational drug(s) / intervention(s)

nerve block with bupivacaine 0.25% →No intervention

nerve block with bupivacaine 0.25%: 0.25% bupivacaine

No intervention: No intervention

Study summary

In this study participants are aiming to compare triple injection peri-sartorius (TIPS) block versus intravenous analgesia for postoperative analgesia after knee arthroscopy regarding efficacy of pain relief and early ambulation

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: .Age 18-40 years undergoing knee arthroscopy. .Sex: Both sexes. .American Society of Anaesthesiologists (ASA) Physical Status Class I and II Exclusion Criteria: .Declining to give written informed consent. .History of allergy to the medications used in the study. .Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection). Psychiatric disorder. .American Society of Anesthesiologists (ASA) Physical Status Class III and IV. * Patients with body mass index (BMI) \>35 kg/m2 .Neurological deficits or mobility-related disorders of the non-operated limb . * Moderate to severe hepatic , renal diseases and cardiac disease.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ain Shams University Cairo Egypt

More Ain Shams University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07046390 on ClinicalTrials.gov ↗ ← All trials in Egypt